Non-squamous, metastatic non-small cell lung cancer: Retrospective c-met overexpression testing, patient characteristics, and treatment patterns

被引:0
|
作者
Cai, Mona H. [1 ]
Choi, Yookyung Christy [1 ]
Vasilopoulos, Athan [1 ]
Liede, Alexander [1 ]
Lindsey, Sidney [2 ]
Raskin, Leon [1 ]
Truong, Ethan [2 ]
Fricke, Jeremy [2 ]
Gruber, Stephen [2 ]
Ansell, Peter [1 ]
机构
[1] AbbVie, N Chicago, IL USA
[2] City Hope Natl Med Ctr, Duarte, CA USA
关键词
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
919
引用
收藏
页码:429 / 429
页数:1
相关论文
共 50 条
  • [31] The role of HGF/C-met signalling pathway on the non-small cell lung cancer
    Gumustekin, M.
    Sis, B.
    Bulut, G.
    Kargi, A.
    Oztop, I.
    Olgun, N.
    Atabey, N.
    FEBS JOURNAL, 2006, 273 : 89 - 89
  • [32] PROTEASOME INHIBITORS REDUCE C-MET IN NON-SMALL CELL LUNG CANCER CELLS
    Li, Yanhui
    Dong, Su
    Tamaskar, Arya
    Wang, Heather
    Zhao, Jing
    Zhao, Yutong
    JOURNAL OF INVESTIGATIVE MEDICINE, 2020, 68 (05) : 1117 - 1118
  • [33] Expression of c-Met and HGF in non-small cell lung carcinomas
    I. V. Korobko
    M. V. Zinov’eva
    E. P. Kopantsev
    A. K. Allakhverdiev
    I. B. Zborovskaya
    E. D. Sverdlov
    Molecular Genetics, Microbiology and Virology, 2007, 22 (2) : 59 - 63
  • [34] HGF/c-Met Overexpressions, but not Met Mutation, Correlates with Progression of Non-small Cell Lung Cancer
    Gumustekin, Mukaddes
    Kargi, Aydanur
    Bulut, Gulay
    Gozukizil, Aysim
    Ulukus, Cagnur
    Oztop, Ilhan
    Atabey, Nese
    PATHOLOGY & ONCOLOGY RESEARCH, 2012, 18 (02) : 209 - 218
  • [35] Efficacy and safety of bevacizumab in the treatment of advanced, non-squamous non-small cell lung cancer (NSCLC)
    Tassinari, D.
    Drudi, F.
    Carloni, F.
    Nicoletti, S.
    Possenti, C.
    Santelmo, C.
    Lazzari, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [36] Maintenance chemotherapy in patients with non-squamous non-small cell lung cancer (NSCLC)
    Belalcazar, A.
    Santos, E. S.
    Gomez, J. E.
    Lopez, E.
    Raez, L. E.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [37] KRAS molecular profiling in non-squamous non-small cell lung cancer (NSCLC).
    Karim, Nagla Abdel
    Starnes, Sandra
    Morris, John
    Pathrose, Peter
    Perry, Ashley
    Fathallah, Hassana
    CLINICAL CANCER RESEARCH, 2014, 20
  • [38] Luminespib plus pemetrexed in patients with non-squamous non-small cell lung cancer
    Noor, Zorawar S.
    Goldman, Jonathan W.
    Lawler, William E.
    Telivala, Bijoy
    Braiteh, Fadi
    DiCarlo, Brian A.
    Kennedy, Kathleen
    Adams, Brad
    Wang, Xiaoyan
    Jones, Benjamin
    Slamon, Dennis J.
    Garon, Edward B.
    LUNG CANCER, 2019, 135 : 104 - 109
  • [39] Molecular landscape of non-squamous, non-small cell carcinoma of the lung
    Weiss, Mia C.
    Leukam, Michael J.
    Villaflor, Victoria M.
    TRANSLATIONAL CANCER RESEARCH, 2015, 4 (04) : 423 - 434
  • [40] A Phase II Study of Metformin with Pemetrexed/Carboplatin in Patients with Metastatic Non-Squamous Non-Small Cell Lung Cancer
    Verma, S.
    Malik, P. S.
    Kalra, K.
    Singh, V.
    Kumar, S.
    Khurana, S.
    Pushpam, D.
    Jain, D.
    Gupta, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S130 - S131